Comparative activities of clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, ofloxacin, sparfloxacin, and trovafloxacin and nonquinolones linozelid, quinupristin-dalfopristin, gentamicin, and vancomycin against clinical isolates of ciprofloxacin-resistant and -susceptible Staphylococcus aureus strains
Me. Jones et al., Comparative activities of clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, ofloxacin, sparfloxacin, and trovafloxacin and nonquinolones linozelid, quinupristin-dalfopristin, gentamicin, and vancomycin against clinical isolates of ciprofloxacin-resistant and -susceptible Staphylococcus aureus strains, ANTIM AG CH, 43(2), 1999, pp. 421-423
The activities of eight fluoroquinolones and linezolid, quinupristin-dalfop
ristin (Synercid), gentamicin, and vancomycin were tested against 96 ciprof
loxacin-susceptible and 205 ciprofloxacin-resistant Staphylococcus aureus s
trains. Overall, clinafloxacin, followed by moxifloxacin and trovafloxacin,
was the most active quinolone tested. For all isolates, linezolid and quin
upristin-dalfopristin showed activities that were at least comparable to va
ncomycin, with no cross-resistance to any other test compound.